Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04878614 · ClinicalTrials.gov registry record · Phase 4
Comparison of Levothyroxine Formulation in Hypothyroid Patients With Enteral Feeding
A Phase 4 study, sponsored by University of California, Los Angeles.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT04878614: Clinical Trial Phase 4 study, sponsored by University of California, Los Angeles.
NCT04878614 is a Phase 4 study that was terminated before completion, run by University of California, Los Angeles. The registered enrollment target is 3 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04878614, a Phase 4 study, was terminated before completion, sponsored by University of California, Los Angeles.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to test a liquid levothyroxine formula and examine if it will lead to improvement in management of thyroid function and if it improves hypothyroid symptoms that patients experience.
Primary Outcome
evaluate change in thyroid hormonal panel
Interventions
- DRUG Levothyroxine Sodium
- DRUG Levothyroxine Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-05-05 |
| Est. Completion | 2022-02-16 |
| Phase | Phase 4 |
Why NCT04878614 stopped before completion
NCT04878614 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Levothyroxine Sodium is the first listed.
NCT04878614 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04878614 about?
NCT04878614 is a clinical study titled "Comparison of Levothyroxine Formulation in Hypothyroid Patients With Enteral Feeding". The purpose of this study is to test a liquid levothyroxine formula and examine if it will lead to improvement in management of thyroid function and if it improves hypothyroid symptoms that patients experience.
What is the current status of trial NCT04878614?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2021-05-05. Estimated completion is 2022-02-16.
What interventions are being tested in trial NCT04878614?
The interventions under investigation include: Levothyroxine Sodium (DRUG), Levothyroxine Tablet (DRUG).
Who is sponsoring clinical trial NCT04878614?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04878614's enrollment target sits among peer trials
3 1995th of 2000 higher than 3 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI